Colesevelam
Links shared publicly online about this topic
Colesevelam improved glycemia, lipids in prediabetes
endocrinetoday.com — “American Association of Clinical Endocrinologists 19th Annual Meeting BOSTON — Patients with high LDL levels and prediabetes experienced” View full resource at endocrinetoday.com
Most Recently Shared on April 26, 2010 at 5:07 pm By:
Colesevelam improved glycemia, lipids in prediabetes http://ow.ly/1Decs #AACE10
Colesevelam HCL Lowers Elevated Glucose Levels in People with Pre-diabetes
hcplive.com — “Colesevelam HCL is effective not only in lowering LDL-cholesterol but” View full resource at hcplive.com
Most Recently Shared on April 26, 2010 at 1:55 pm By:
#AACE10 Colesevelam HCL Lowers Elevated Glucose Levels in People with Pre-diabetes http://bit.ly/cuGiow
Pediatrics Medical News about Hyperlipoproteinemia Type II Colesevelam
mdlinx.com — “Colesevelam: In Pediatric Patients with Heterozygous Familial Hypercholesterolemia” View full resource at mdlinx.com
Most Recently Shared on March 24, 2010 at 4:23 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Colesevelam: In Pediatric Patients with Heterozygous Familial Hypercholesterolemia: Pediatric Drugs http://bit.ly/cMzHp8 #peds
Combination colesevelam hydrochloride plus metformin improved glycemic control, LDL
endocrinetoday.com — “American Association of Clinical Endocrinologists 18th Annual Meeting Colesevelam hydrochloride, a bile acid sequestrant, shows promise as a” View full resource at endocrinetoday.com
Most Recently Shared on May 15, 2009 at 6:51 pm By:
AACE meeting ... Combination colesevelam hydrochloride plus metformin improved glycemic control, LDL: http://tinyurl.com/colesev
Welchol (colesevelam HCl) Receives FDA Approval to Lower LDL Cholesterol in Pediatric Patients with Heterozygous Familial Hypercholesterolemia
drugs.com — “Welchol (colesevelam HCl) is used to treat Pediatric Patients with Heterozygous Familial Hypercholesterolemia. Includes Welchol side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 7, 2009 at 10:47 pm By:
FDA Approves Welchol for Pediatric Patients with Heterozygous Familial Hypercholesterolemia - http://bit.ly/BU6lG
Colesevelam Improves Oral but Not Intravenous Glucose Tolerance by a Mechanism Independent of Insulin Sensitivity and ?-Cell Function
care.diabetesjournals.org — “Colesevelam Improves Oral but Not Intravenous Glucose Tolerance by a Mechanism Independent of Insulin Sensitivity and ?-Cell Function” View full resource at care.diabetesjournals.org
Most Recently Shared on March 24, 2012 at 11:07 am By:
James Underberg Internist, Physician, and Doctor
#Welchol #Colesevelam Improves Oral Not IV Glucose Tolerance. ?Explained by the colesevelam-induced increase in CCK. http://t.co/1cyM0nJb
Once-daily colesevelam received approval to be mixed with fruit juice, diet soft drinks
endocrinetoday.com — “Daiichi Sankyo announced this week that the FDA approved a supplemental new drug application for colesevelam hydrochloride for oral suspension t” View full resource at endocrinetoday.com
Most Recently Shared on July 27, 2011 at 2:07 pm By:
Once-daily colesevelam received approval to be mixed with fruit juice, diet soft drinks http://bit.ly/pMeVR1
Once-Daily Welchol (colesevelam HCl) for Oral Suspension Receives FDA Approval To be Mixed With Fruit Juice or Diet Soft Drinks
drugs.com — “Welchol (colesevelam) is used to treat patients with heterozygous familial hypercholesterolemia and to improve glycemic control in adults with type 2 diabetes mellitus. Includes Welchol side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 26, 2011 at 1:01 am By:
Drugs and Devices OW OW Health
Once-Daily Welchol (colesevelam HCl) for Oral Suspension Receives FDA Approval To be Mixed With Fruit Juic... http://bit.ly/nBCAIo #drug
News - Colesevelam Can Help Reduce LDL-C, Improve Metabolic Profile in Patients With High Cholesterol and Prediabetes: Presented at EASD
docguide.com — “Colesevelam Can Help Reduce LDL-C, Improve Metabolic Profile in Patients With High Cholesterol and P” View full resource at docguide.com
Most Recently Shared on September 24, 2010 at 9:54 pm By:
Symposier Endocrino Health Site
Colesevelam Can Help Rduce LDL-C, Improve Metabolic Profile in Patients With High Cholesterol and Prediabetes http://bit.ly/ddd3nv #EASD2010
theheart.org: Cardiology news, educational programming, and opinions
theheart.org — “TheHeart.org is the most trusted source for cardiology news, commentary and continuing medical education on the web.” View full resource at theheart.org
Most Recently Shared on October 9, 2009 at 5:10 pm By:
FDA clears colesevelam for familiar hypercholesterolemia in kids http://www.theheart.org/article/1012103.do
Impax Laboratories Confirms Patent Challenge Relating To WELCHOL(R) 625 Mg Tablets
medicalnewstoday.com — “Impax Laboratories, Inc. (NASDAQ:IPXL) confirms that it has initiated a challenge of patents listed by Daiichi Sankyo, Inc. in connection with its WELCHOL® (Colesevelam HCl) tablets, 625 mg.” View full resource at medicalnewstoday.com
Most Recently Shared on January 18, 2010 at 3:37 pm By:
Impax Laboratories Confirms Patent Challenge Relating To WELCHOL(R) 625 Mg Tablets Impax Laboratories, Inc. (NASDAQ:I.. http://bit.ly/7DgyIH
Endocrinology Article | Hypercholesterolemia
mdlinx.com — “Colesevelam: an improved bile acid sequestrant for treating hypercholesterolemia and improving diabetes” View full resource at mdlinx.com
Most Recently Shared on December 21, 2010 at 5:27 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Colesevelam: an improved bile acid sequestrant for treating hypercholesterolemia and improving diabetes: E... http://bit.ly/fK4vlu #endo
KineMed Receives An Investigator-Initiated Study Grant To Further Explore Mechanism(s) Of Action Associated With Welchol® In Type 2 Diabetes Melli
medicalnewstoday.com — “Kinemed, inc., a translational and personalized medicine development company, announced today that the company has received an investigator initiated study grant from daiichi sankyo, inc. to condu” View full resource at medicalnewstoday.com
Most Recently Shared on November 21, 2009 at 8:00 am By:
KineMed Receives An Investigator-Initiated Study Grant To Further Explore Mechanism(s) Of Action Associated Wit.. http://bit.ly/088sbnR
Endocrinology Article | Diabetes Mellitus, Type 2
mdlinx.com — “Colesevelam HCI Added to Background Metformin Therapy in Patients With Type 2 Diabetes Mellitus: A Pooled Analysis From Three Clinical Studies” View full resource at mdlinx.com
Most Recently Shared on August 24, 2011 at 11:09 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Colesevelam HCI Added to Background Metformin Therapy in Patients With Type 2 Diabetes Mellitus: A Poo... http://t.co/OzFhLtn #diabetes
Endocrinology Article | Diabetes Mellitus, Type 2
mdlinx.com — “Colesevelam HCI Added to Background Metformin Therapy in Patients With Type 2 Diabetes Mellitus: A Pooled Analysis From Three Clinical Studies” View full resource at mdlinx.com
Most Recently Shared on August 24, 2011 at 11:53 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Colesevelam HCI Added to Background Metformin Therapy in Patients With Type 2 Diabetes Mellitus: A Pooled ... http://t.co/vFKKJpe #endo
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Endocrine Today
The official Twitter for Endocrine Today, clinical news on diabetes and endocrine disorders.
-
HCPLive
Your online destination for Endocrinology news,events, and resources
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
